SCHEMBL8873371

SCHEMBL8873371

COc1ccccc1C1(O)CCCC2CNCC21

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.48
CHRM4 P08173 2/20 0.46
CHRM2 P08172 1/20 0.46
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
TACR1 P25103 2/20 0.39
KMT2A Q03164 1/20 0.37
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
OPRL1 P41146 1/20 0.36
HTR2C P28335 2/20 0.35
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
MAPT P10636 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8874373 0.79 SIGMAR1 (0.44) SIGMAR1CHRM4CHRM2CHRM5CHRM1
SCHEMBL8875726 0.79 SIGMAR1 (0.44) SIGMAR1CHRM4CHRM2CHRM5CHRM1
SCHEMBL8874988 0.79 SIGMAR1 (0.44) SIGMAR1CHRM4CHRM2CHRM5CHRM1
SCHEMBL8874651 0.78 SIGMAR1 (0.46) SIGMAR1CHRM4CHRM2CHRM5CHRM1
Hydrochloric Acid SCHEMBL8874914 0.78 SIGMAR1 (0.49) SIGMAR1CHRM4CHRM2CHRM5CHRM1
SCHEMBL8544913 0.77 TACR1 (0.56) SIGMAR1CHRM4CHRM2CHRM5CHRM1
SCHEMBL8875102 0.77 SIGMAR1 (0.45) SIGMAR1CHRM4CHRM2CHRM5CHRM1
Hydrochloric Acid SCHEMBL7886015 0.76 TACR1 (0.55) SIGMAR1CHRM4CHRM2CHRM5CHRM1
Hydrochloric Acid SCHEMBL9241561 0.76 TACR1 (0.55) SIGMAR1CHRM4CHRM2CHRM5CHRM1
Hydrochloric Acid SCHEMBL8956731 0.76 TACR1 (0.55) SIGMAR1CHRM4CHRM2CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624950-A USEFUL IN TREATMENT OF ANALGESIA, INFLAMMATION, ASTHMA, ALLERGIES, CENTRAL NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS, IMMUNE SYSTEM DISORDERS, ANTISPASMODIC AGENTS, ANTIEMETIC AGENTS RHONE-POULENC RORER S.A. (FR) 1997-04-29 US disclosed